Abstract:Hepatitis C-positive liver transplantation (LT) patients present significant problems in post-transplant management. These patients are known to have more rapid fibrosis progression, and outcomes are worsening in the population, compared to other indications for LT. Decisions regarding selection of immunosuppressants and treatment of rejection are different in these patients, because both may alter the course of progression. HCV recurs universally, and treatment of recurrence is fraught with difficulties in to… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.